Eltrombopag

Thrombopoietin Receptor Agonist

Brands

Promacta

Eltrombopag Oral Suspension

DosageBrandImage
eltrombopag 12.5 MG Powder for Oral SuspensionGeneric
eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]Generic
eltrombopag 25 MG Powder for Oral SuspensionGeneric
eltrombopag 25 MG Powder for Oral Suspension [Promacta]Generic

Eltrombopag Oral Tablet

DosageBrandImage
eltrombopag 12.5 MG Oral TabletGeneric
eltrombopag 12.5 MG Oral Tablet [Promacta]Generic
eltrombopag 25 MG Oral TabletGeneric
eltrombopag 25 MG Oral Tablet [Promacta]GenericORANGE ROUND GS;NX3;25 eltrombopag 25 MG Oral Tablet [Promacta]
eltrombopag 50 MG Oral TabletGeneric
eltrombopag 50 MG Oral Tablet [Promacta]GenericBLUE ROUND GS;UFU;50 eltrombopag 50 MG Oral Tablet [Promacta]
eltrombopag 75 MG Oral TabletGeneric
eltrombopag 75 MG Oral Tablet [Promacta]GenericRED ROUND GSFFS;75 eltrombopag 75 MG Oral Tablet [Promacta]

Eltrombopag desired effects:

  • Increased Platelet Production
  • Increased Megakaryocyte Maturation

Eltrombopag drug classes:

  • Thrombopoietin Receptor Agonist

Eltrombopag mechanism of action:

  • UGT1A3 Inhibitors
  • UGT2B7 Inhibitors
  • UGT1A6 Inhibitors
  • UGT1A9 Inhibitors
  • UGT1A4 Inhibitors
  • Thrombopoietin Receptor Agonists
  • Breast Cancer Resistance Protein Inhibitors
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors
  • UGT2B15 Inhibitors
  • UGT1A1 Inhibitors
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Questions? Call or text: 859-651-7603

LegitScript approved
Copyright © Treatable 2023
Last updated: 1/29/2025, 11:11:51 PM